Search results
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive· 20 hours agoSales data suggest forecasts for the Alzheimer’s drug may be in reach. Elsewhere, Ipsen is licensing...
Sales data suggest forecasts for the Alzheimer’s drug may be in reach. Elsewhere, Ipsen is licensing...